Jan 19, 2021 / 10:30AM GMT
Operator
Ladies and gentlemen, good day, and welcome to the Alembic Pharmaceuticals Limited Q3 FY '21 Earnings Conference Call. We have with us today from the management, Mr. Pranav Amin, Managing Director; Mr. Shaunak Amin, Managing Director; Mr. R.K. Baheti, Director, Finance and CFO; Mr. Mitanshu Shah, Head, Finance; Mr. Jesal Shah, Head Strategy; and Mr. Ajay Kumar Desai, Senior Vice President, Finance. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. R.K. Baheti, Director, Finance and CFO. Thank you, and over to you, sir.
Raj Kumar Shreeram Baheti - Alembic Pharmaceuticals Limited - Director of Finance, CFO & Executive Director
Thank you very much. Good evening, everyone. Thank you all for joining the third quarter results conference call. I'm sure you would have received the results by now. However, let me briefly take you through the numbers for the quarter ended 9 months ended 31st March 2020 -- I'm sorry, 31st December 2020.
Let me begin with financials first. During the
Q3 2021 Alembic Pharmaceuticals Ltd Earnings Call Transcript
Jan 19, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers